with GMail, and scheduling and description tips for daily diaries at the mSquared (Medrio) users’ conference in March of 2017. At that same event I moderated a panel on Clinical Study Build Validation. This Year, we returned to the mSquared conference in March but didn’t present. At the end of June, I’ll be attending the DIA (Drug Information Association) conference in Boston. And in September, Tom and I are expected to attend the SCDM (Society of Clinical Data Management) conference in Seattle. If you are attending either the Dia or SCDM conferences, please make sure to make sure to connect with me. What does 2018 look like for DFS Pharma? RM: 2018 looks great for DFS Pharma. 2016 was our best revenue generating year to date and saw the company add to its headcount. 2017 was a continuation of 2016. Looking at the partnerships that we have, both with our vendors and our existing clients, coupled with the increas- ing number of proposal requests we’ve gotten this year, we expect to continue our growth in 2018. Long term, we hope to continue to expand the number of partners we have to continue to provide greater and greater flexibility and client focus thereby delivering high quality data
for regulatory submission and a healthier, happier populace.
Rod spoke with Spotlight on Business Magazine in late June fromDFS Pharma headquarters inWilmington, North Carolina. DFS Pharma can be contacted via Linkedin, on Twitter as @DFSPharm, or through Facebook and Google Plus.
77
JUNE 2018 • SPOTLIGHT ON BUSINESS MAGAZINE
Made with FlippingBook - professional solution for displaying marketing and sales documents online